---
document_datetime: 2023-09-21 19:40:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ketek-epar-all-authorised-presentations_en.pdf
document_name: ketek-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.008277
conversion_datetime: 2025-12-19 02:15:57.105067
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Packaging                              | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|----------------------------------------|----------------|
| EU/1/01/191/001 | Ketek           | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Aluminium)                | 10 tablets     |
| EU/1/01/191/002 | Ketek           | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Aluminium)                | 14 tablets     |
| EU/1/01/191/003 | Ketek           | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Aluminium)                | 20 tablets     |
| EU/1/01/191/004 | Ketek           | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Aluminium)                | 100 tablets    |
| EU/1/01/191/005 | Ketek           | 400 mg     | Film-coated tablet    | Oral use                  | perforated unit dose blister (PVC/Alu) | 5 x 2 tablets  |

1/1

Medicinal product no longer authorised